ClinicalTrials.gg
Sign In

Diabetic Neuropathies clinical trials

The registry lists 538 studies for Diabetic Neuropathies across more than 10 countries. 80 are recruiting or about to start. 398 of them are mainly about Diabetic Neuropathies (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-12. Counting its narrower condition Diabetic Foot too: 1,566 studies, 293 open.

ClinicalTrials.gov finds 1,824 studies for Diabetic Neuropathies. How that becomes 538 here

This page counts the studies the registry files under Diabetic Neuropathies, and those it files under no condition that list Diabetic Neuropathiesthemselves. Each study its search finds is placed by how the registry filed it and by the conditions it lists. ClinicalTrials.gov counts as of Nov 8, 2026. How condition pages count

  1. 1,824Found by its condition searchIt reads the conditions a study lists and their synonyms, and also titles and keywords.
  2. −983Filed under a narrower condition, counted on its own pageDiabetic Foot 983
  3. −14List Diabetic Neuropathies as a condition, but the registry did not file them under itMost often written as “Diabetic Neuropathy Peripheral” (7), “Peripheral Diabetic Neuropathy” (4), and “Diabetes With Diabetic Autonomic Neuropathy (Diagnosis)” (2). The registry filed them under other conditions only, most often Diabetes Mellitus (6) and Diabetes Mellitus, Type 2 (3).
  4. −291Match it another way52 name it in the title, 2 in a keyword, and 237 by a synonym or other text the search reads.
  5. 536Counted here and found by its search12 of them list Diabetic Neuropathies in their own words; the registry filed them under no condition.
  6. +2
    Counted here, but its search does not find them
  7. 538The count on this page

Get an email when these change. Save the Diabetic Neuropathies studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
342
Recruiting
52
Status unknown
51
Terminated
33
Not yet recruiting
24
Active, not recruiting
16

Phase

Phase 2
122
Phase 3
77
Phase 4
44
Phase 1
29
Early Phase 1
2

Where

United States
158
Pakistan
45
Germany
37
Egypt
31
Denmark
30
Turkey
28

Who runs them

Riphah International University (24) · Eli Lilly and Company (12) · Pfizer's Upjohn has merged with Mylan to form Viatris Inc. (10) · UCB Pharma (9) · Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (7) · Cairo University (7) · Aalborg University Hospital (6) · Sangamo Therapeutics (5)

What is being tested here

Drugs under test in Diabetic Neuropathies studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Botulinum toxin type A205
DLBS 1033212
Adezunap222
Pregabalin11017
Capsaicin126
Lidocaine104
Cannabidiol102
Medication101
Melatonin101
Naltrexone101

Drug classes tested here SNRIs 15 · Opioids 7

Coming up

6phase 3 studies under way
31studies finish main data collection within a year1 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 52 Diabetic Neuropathies studies recruiting now, 21 (40%) set no upper age limit and 24 (46%) stop at 75 or younger. 6 (12%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 3 (6%) take healthy volunteers.

Recruiting studies that take each age, of 52
AgeWomenMen
104 (8%)4 (8%)
1835 (67%)35 (67%)
3033 (63%)33 (63%)
4041 (79%)41 (79%)
5046 (88%)46 (88%)
6543 (83%)43 (83%)
7534 (65%)34 (65%)
8524 (46%)24 (46%)

Across all 538 studies, recruiting or not: 43% stop at 75 or younger and 16% at 65; 4% take children; 1% are for women only and 1% for men only; 13% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Diabetic Neuropathies studies take

Of 25 phase 2 interventional studies under Diabetic Neuropathies, half reached primary completion within 20 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 220 mo14–35 · 25 studies——
Phase 417 mo9–30 · 11 studies——
Interventional, no phase12 mo6–28 · 152 studies—11 mo6–24 · 137 studies
Observational25 mo6–47 · 19 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 14, 2026.

Started recruiting1

Results posted1

Newly registered3

Studies

Recruiting first, then most recently updated. Showing 50 of 538. Browse all 538 → or search them.